Corcept Therapeutics CORT
NASDAQ CORT
$114.74 -0.89 (-0.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Corcept Therapeutics (CORT) Operating Margin (2012 - 2026)

Updated

Corcept Therapeutics (CORT) reported Operating Margin of 16.12% for Q2 2026, up 2.40 percentage points from 13.72% a year earlier and up 46.20 percentage points from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Operating Margin (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Corcept Therapeutics' Operating Margin came in at 0.77%, down 13.47 percentage points year-over-year; for FY2025, it came in at 5.88%, down 14.40 percentage points from FY2024.

  • Operating Margin has declined for six consecutive years, with a five-year change of -30.34 percentage points (FY2020 to FY2025).
  • By year, Operating Margin came in at 20.29% in FY2024 (-1.95 pp), 22.24% in FY2023 (-5.79 pp), 28.03% in FY2022 (-5.98 pp) and 34.01% in FY2021 (-2.22 pp).
  • The Q2 2026 figure ranks as the highest quarterly Operating Margin since Q3 2024.
  • Year over year, Operating Margin gained in two of the last eight quarters, with an average year-over-year change of -12.16 percentage points.
  • The high point for year-over-year Operating Margin in five years was Q3 2021 (a gain of 9.06 percentage points); the low point was Q1 2026 (a drop of 32.25 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -30.08% (Q1 2026), 2.22% (Q4 2025) and 4.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Corcept Therapeutics 12.50 Bn 11.06 Bn 252.09 Mn 16.12%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.12%
Mar 31, 2026 -30.08%
Dec 31, 2025 2.22%
Sep 30, 2025 4.92%
Jun 30, 2025 13.72%
Mar 31, 2025 2.17%
Dec 31, 2024 13.89%
Sep 30, 2024 25.53%
Jun 30, 2024 21.73%
Mar 31, 2024 20.09%
Dec 31, 2023 23.39%
Sep 30, 2023 25.22%
Jun 30, 2023 25.13%
Mar 31, 2023 14.06%
Dec 31, 2022 21.83%
Sep 30, 2022 31.39%
Jun 30, 2022 30.40%
Mar 31, 2022 28.57%
Dec 31, 2021 37.10%
Sep 30, 2021 37.69%
API Access

Corcept Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=CORT&period=max&api_key=YOUR_API_KEY